Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8200-8206
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8200
Table 2 Correlation between CTAs and clinicopathological factors n (%)
CharacteristicsThe expression number of each CTA
KK-LC-1MAGE-A1MAGE-A3NY-ESO-1
Age (yr) (mean ± SD)P = 0.944P = 0.104P = 0.009P = 0.042
Positive69.8 ± 11.4 (n = 66)72.7 ± 7.9 (n = 27)73.7 ± 7.1 (n = 33)75.5 ± 7.2 (n = 13)
Negative70.1 ± 9.5 (n = 17)68.5 ± 12.0 (n = 56)67.4 ± 12.3 (n = 50)68.8 ± 11.2 (n = 70)
Tumor size (mm) (mean ± SD)P = 0.5202P = 0.4752P = 0.862P = 0.831
Positive59.9 ± 4.2 (n = 65)62.5 ± 6.6 (n = 27)57.9 ± 5.9 (n = 33)60.5 ± 9.5 (n = 13)
Negative53.8 ± 8.5 (n = 16)56.8 ± 4.6 (n = 54)59.2 ± 4.9 (n = 48)58.3 ± 4.1 (n = 68)
GenderP = 0.406P = 1P = 0.645P = 0.758
Male (n = 52)43 (82.7)17 (32.7)22 (42.3)9 (17.3)
Female (n = 31)23 (74.2)10 (32.3)11 (35.5)4 (12.9)
Macroscopic typeP = 0.591P = 1P = 0.649P = 1
Localized (n = 49)40 (81.6)16 (32.7)18 (36.7)8 (16.3)
Infiltrated (n = 34)26 (76.5)11 (32.4)15 (44.1)5 (14.7)
Histological typeP = 0.599P = 0.246P = 1P = 1
Differentiated (n = 44)36 (81.8)17 (38.6)18 (40.9)7 (15.9)
Undefferentiated (n = 39)30 (76.9)10 (25.6)15 (38.5)6 (15.4)
Depth of invasionP = 0.269P = 0.089P = 0.243P = 0.761
T1 (n = 30)26 (86.7)6 (20.0)9 (30.0)4 (13.3)
Intramucosal (n = 11)11 (100)0 (0)2 (18.2)1 (9.1)
Submucosal 1 (n = 5)4 (80.0)2 (40.0)3 (60.0)1 (20.0)
Submucosal 2 (n = 14)11 (78.6)4 (28.6)4 (28.6)2 (14.3)
T2-T4 (n = 53)40 (75.5)21 (39.6)24 (45.3)9 (17.0)
Lymph node metastasisP = 1P = 0.17P = 0.823P = 1
Negative (n = 40)32 (80.0)10 (25.0)15 (37.5)6 (15.0)
Positive (n = 43)34 (79.1)17 (39.5)18 (41.9)7 (16.3)
Lymphatic invasionP = 1P = 0.034P = 0.022P = 0.498
Negative (n = 22)18 (81.8)3 (13.6)4 (18.2)2 (9.1)
Positive (n = 61)48 (78.7)24 (39.3)29 (47.5)11 (18.0)
Venous invasionP = 0.583P = 0.028P = 0.035P = 0.121
Negative (n = 30)25 (83.3)5 (16.7)7 (23.3)2 (6.7)
Positive (n = 53)41 (77.4)22 (41.5)26 (49.1)11 (20.8)
StageP = 1P = 0.162P = 0.044P = 0.222
Early (I) (n = 34)27 (79.4)8 (23.5)9 (26.5)3 (8.8)
Advanced (II-IV) (n = 49)39 (79.6)19 (38.8)24 (49.0)10 (20.4)
II (n = 21)16 (76.2)7 (33.3)11 (52.4)3 (14.3)
III (n = 15)11 (73.3)7 (46.7)7 (46.7)3 (20.0)
IV (n = 13)12 (92.3)5 (38.5)6 (46.2)4 (30.8)